We are live on ! Find out more
NGNE icon

Neurogene
NGNE

81 hedge funds and large institutions have $49.7M invested in Neurogene in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $337K | Put options by funds: $246K

1% more funds holding

Funds holding: 80 → 81 (+1)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0.01% less ownership

Funds ownership: 2.91% → 2.89% (-0.01%)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

58% less capital invested

Capital invested by funds: $119M → $49.7M (-$69M)

Holders
81
Holders Change
+1
Holders Change %
+1.25%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
25
Reduced
26
Closed
14
Calls
$337K
Puts
$246K
Net Calls
+$91K
Net Calls Change
-$1.01M

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$1.34M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.24M
3
Millennium Management
Millennium Management
New York
+$1.19M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$625K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$317K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$4.15M
2
Alkeon Capital Management
Alkeon Capital Management
New York
-$1.08M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$932K
4
OM
Opaleye Management
Massachusetts
-$751K
5
JP Morgan Chase
JP Morgan Chase
New York
-$431K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$7.18M – – –
RG
2
Redmile Group
California
$6.51M -$74.1K -1,270 -0.7%
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$4.84M +$117 +2 +0%
BlackRock
4
BlackRock
New York
$4.81M -$135K -2,308 -2%
Osaic Holdings
5
Osaic Holdings
Arizona
$3.39M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.41M -$932K -15,975 -20%
Renaissance Technologies
7
Renaissance Technologies
New York
$2.39M +$1.24M +21,267 +50%
Millennium Management
8
Millennium Management
New York
$2.32M +$1.19M +20,322 +49%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$2.3M +$625K +10,710 +21%
OM
10
Opaleye Management
Massachusetts
$1.49M -$751K -12,865 -25%
CS
11
Candriam SCA
Luxembourg
$1.47M -$223K -3,830 -9%
Morgan Stanley
12
Morgan Stanley
New York
$1.27M +$228K +3,906 +13%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.1M -$4.78K -82 -0.3%
State Street
14
State Street
Massachusetts
$1.1M +$16.5K +282 +1%
Barclays
15
Barclays
United Kingdom
$861K +$1.34M +22,898 New
Northern Trust
16
Northern Trust
Illinois
$581K -$51.5K -883 -5%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$543K +$158K +2,715 +23%
Two Sigma Investments
18
Two Sigma Investments
New York
$459K +$257K +4,404 +56%
Bank of America
19
Bank of America
North Carolina
$399K +$60.2K +1,031 +11%
ACM
20
ACT Capital Management
Pennsylvania
$374K -$39.4K -675 -6%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$324K +$317K +5,440 +172%
RA
22
Royce & Associates
New York
$273K – – –
KCM
23
Kynam Capital Management
New Jersey
$264K -$19K -325 -4%
N
24
Nuveen
North Carolina
$252K +$4.32K +74 +1%
GCP
25
GSA Capital Partners
United Kingdom
$240K -$8.81K -151 -2%
1
2 3 4

NGNE Hedge Fund Activity: Q1 2022 in Review

81 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2022, worth a combined $49.7M — down 58% from $119M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NGNE positions and 14 closed out — a net gain of 1 holder — while 25 added to existing stakes and 26 trimmed.

The largest buyer was Barclays, opening a new position worth an estimated $1.34M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $4.15M sold.

  • 81 institutional investors held Neurogene (NGNE) as of Q1 2022, up from 80 in Q4 2021.
  • Funds reported $49.7M of Neurogene stock for Q1 2022, down 58% quarter-over-quarter.
  • 15 funds opened new Neurogene positions in Q1 2022 and 14 closed out, a net change of +1 holder.
  • The largest Neurogene buyer in Q1 2022 was Barclays, an estimated $1.34M added.
  • The largest Neurogene seller in Q1 2022 was EcoR1 Capital, an estimated $4.15M sold.

Based on aggregated 13F filings for Q1 2022.